APA (7th ed.) Citation

R, C., N, S., M, H., P, P., M, M., S, R., . . . JP, A. (2024). Global Hemostatic Methods to Tailor Treatment With Bypassing Agents in Hemophilia A With Inhibitors- A Single-Center, Pilot Study. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 30, 10760296241260053. https://doi.org/10.1177/10760296241260053

Chicago Style (17th ed.) Citation

R, Chaireti, Soutari N, Holmström M, Petrini P, Magnusson M, Ranta S, Pruner I, and Antovic JP. "Global Hemostatic Methods to Tailor Treatment With Bypassing Agents in Hemophilia A With Inhibitors- A Single-Center, Pilot Study." Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 30 (2024): 10760296241260053. https://doi.org/10.1177/10760296241260053.

MLA (9th ed.) Citation

R, Chaireti, et al. "Global Hemostatic Methods to Tailor Treatment With Bypassing Agents in Hemophilia A With Inhibitors- A Single-Center, Pilot Study." Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, vol. 30, 2024, p. 10760296241260053, https://doi.org/10.1177/10760296241260053.